Today in trading, Medicenna Therapeutics Corp shares opened at $1.59 and closed at $1.55. Intraday prices ranged from $1.52 to $1.64.

The price advanced 1.31 percent from the previous day's close of $1.53.

Today across North America, the TSX Composite closed tsx_percentage_change% at 22011.72, the S&P 500 closed sp_500_percentage_change% at 5010.60, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 38239.98 and the Nasdaq Composite closed nasdaq_percentage_change% at 15451.31.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

A total of 70,982 shares was traded during the last trading day, with total trades of 154, with an average volume of 112,658 over the last 5 days.

The TSX overall saw 3,894 price advancers against 1,317 declines and 99 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.10 (March 28,2024) and low as $0.22 (November 01,2023). Moreover, the shares have soared 84.52 percent in 52 weeks, while in 2024, they have risen 269.05%.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $106.55 million on a float of 69,637 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Based on 2.00 analysts, Medicenna Therapeutics Corp gets an average recommendation of "Strong Buy" according to Zacks. From those 2 analysts, 2 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..